ProQR Therapeutics (PRQR) Total Non-Current Liabilities (2013 - 2026)
ProQR Therapeutics (PRQR) recorded Total Non-Current Liabilities of $22.32 million in the quarter ended Jun 30, 2026, down 47.4% from $42.41 million a year earlier and down 27.7% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, ProQR Therapeutics reported Total Non-Current Liabilities of $34.96 million, down 20.2% from the prior year.
- Annual Total Non-Current Liabilities has declined for three straight years, with a five-year compound annual growth rate of -0.8% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Total Non-Current Liabilities came in at $43.83 million in the year ended Dec 31, 2024 (-35.0%), $67.38 million in the year ended Dec 31, 2023 (-23.6%), $88.17 million in the year ended Dec 31, 2022 (+8.4%) and $81.36 million in the year ended Dec 31, 2021 (+123.5%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Total Non-Current Liabilities since the quarter ended Dec 31, 2019.
- On a year-over-year basis, Total Non-Current Liabilities has declined for 11 consecutive quarters, with an average decline of 38.1% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 106.9% in the quarter ended Dec 31, 2021, against a decline of 57.4% in the quarter ended Mar 31, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $30.88 million (quarter ended Mar 31, 2026), $36.02 million (quarter ended Dec 31, 2025) and $39.91 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | ProQR Therapeutics | 145.89 Mn | -314.77 Mn | - | 21.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.93 Mn |
| Mar 31, 2026 | 30.23 Mn |
| Dec 31, 2025 | 36.35 Mn |
| Sep 30, 2025 | 40.05 Mn |
| Jun 30, 2025 | 43.94 Mn |
| Mar 31, 2025 | 42.25 Mn |
| Dec 31, 2024 | 42.14 Mn |
| Sep 30, 2024 | 47.17 Mn |
| Jun 30, 2024 | 91.04 Mn |
| Mar 31, 2024 | 95.72 Mn |
| Dec 31, 2023 | 68.94 Mn |
| Sep 30, 2023 | 100.81 Mn |
| Jun 30, 2023 | 104.46 Mn |
| Mar 31, 2023 | 107.65 Mn |
| Dec 31, 2022 | 89.18 Mn |
| Sep 30, 2022 | 52.66 Mn |
| Jun 30, 2022 | 93.44 Mn |
| Mar 31, 2022 | 98.81 Mn |
| Dec 31, 2021 | 77.86 Mn |
| Sep 30, 2021 | 75.46 Mn |
API Access
ProQR Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();